This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (126)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Bacterial Infections  • Alert me on articles by topic

Stephan Harbarth, MD; Olivier Rutschmann, MD; Philippe Sudre, MD, MS; Didier Pittet, MD, MS

Arch Intern Med. 1998;158:182-189.

Background  Uncertainties remain about the contribution of methicillin resistance to morbidity and mortality associated with bacteremia caused by Staphylococcus aureus.

Objective  To assess the impact of methicillin resistance on patient outcome after staphylococcal bacteremia.

Methods  We investigated a cohort of 145 patients with methicillin-sensitive S aureus bloodstream infection (MSSA BSI) and 39 patients with methicillin-resistant S aureus bloodstream infection (MRSA BSI) and further performed a pairwise-matched (1:1) case-control study. All patients in the University Hospital of Geneva, Geneva, Switzerland, with clinically significant staphylococcal bacteremia between January 1, 1994, and December 31, 1995, were included in the study. For the case-control study, cases were defined as patients with MRSA BSI; control patients with MSSA BSI were selected in a stepwise manner according to the following matching variables: age, sex, number of comorbidities, severity of underlying illness, and prior length of stay in the hospital. Matching was successful for 97% of the cohort.

Main Outcome Measure  The in-hospital mortality after staphylococcal bacteremia.

Results  In the population-based study, the relative hazard of death among patients with MRSA BSI (n=39, 14 deaths, 36% fatality rate) compared with patients with MSSA BSI (n=145, 40 deaths, 28% fatality rate) was 1.1 (95% confidence interval, 0.5-2.1), after adjusting for age and length of stay from admission to the onset of bloodstream infection. Following pairwise matching (n=38), the in-hospital mortality was 34% in both groups (odds ratio, 1.0; 95% confidence interval, 0.4-2.5). Infection was the probable or definite cause of death in 54% of patients with MRSA BSI and 69% of patients with MSSA BSI who died.

Conclusion  Methicillin resistance in patients with S aureus bacteremia had no significant impact on patient outcome as measured by in-hospital mortality after adjustment was made for major confounders.

From the Infection Control Program, Division of Infectious Diseases, Department of Internal Medicine, University Hospital of Geneva, Geneva, Switzerland.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Rapid Differentiation of Methicillin-Resistant Staphylococcus aureus and Methicillin-Susceptible Staphylococcus aureus from Blood Cultures by Use of a Direct Cefoxitin Disk Diffusion Test
Bennett and Sharp
J. Clin. Microbiol. 2008;46:3836-3838.
ABSTRACT | FULL TEXT  

Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin
Lodise et al.
Antimicrob. Agents Chemother. 2008;52:3315-3320.
ABSTRACT | FULL TEXT  

Accuracy and Potential Usefulness of Triplex Real-Time PCR for Improving Antibiotic Treatment of Patients with Blood Cultures Showing Clustered Gram-Positive Cocci on Direct Smears
Ruimy et al.
J. Clin. Microbiol. 2008;46:2045-2051.
ABSTRACT | FULL TEXT  

Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review
Athanassa et al.
Eur Respir J 2008;31:625-632.
ABSTRACT | FULL TEXT  

Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis
Tacconelli et al.
J Antimicrob Chemother 2008;61:26-38.
ABSTRACT | FULL TEXT  

Outcome of Vancomycin Treatment in Patients with Methicillin-Susceptible Staphylococcus aureus Bacteremia
Kim et al.
Antimicrob. Agents Chemother. 2008;52:192-197.
ABSTRACT | FULL TEXT  

Prevention of Infective Endocarditis: Guidelines From the American Heart Association: A Guideline From the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group
Wilson et al.
Circulation 2007;116:1736-1754.
ABSTRACT | FULL TEXT  

Methicillin resistant Staphylococcus aureus infections following cardiac surgery: incidence, impact and identifying adverse outcome traits
Reddy et al.
Eur. J. Cardiothorac. Surg. 2007;32:113-117.
ABSTRACT | FULL TEXT  

Clinical Validation of the Molecular BD GeneOhm StaphSR Assay for Direct Detection of Staphylococcus aureus and Methicillin-Resistant Staphylococcus aureus in Positive Blood Cultures
Stamper et al.
J. Clin. Microbiol. 2007;45:2191-2196.
ABSTRACT | FULL TEXT  

Concurrent Analysis of Nose and Groin Swab Specimens by the IDI-MRSA PCR Assay Is Comparable to Analysis by Individual-Specimen PCR and Routine Culture Assays for Detection of Colonization by Methicillin-Resistant Staphylococcus aureus.
Bishop et al.
J. Clin. Microbiol. 2006;44:2904-2908.
ABSTRACT | FULL TEXT  

Time to Blood Culture Positivity as a Predictor of Clinical Outcome of Staphylococcus aureus Bloodstream Infection
Marra et al.
J. Clin. Microbiol. 2006;44:1342-1346.
ABSTRACT | FULL TEXT  

Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK
Gemmell et al.
J Antimicrob Chemother 2006;57:589-608.
ABSTRACT | FULL TEXT  

Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: impact on the outcome
Fang et al.
J Antimicrob Chemother 2006;57:511-519.
ABSTRACT | FULL TEXT  

Does Nasal Cocolonization by Methicillin-Resistant Coagulase-Negative Staphylococci and Methicillin-Susceptible Staphylococcus aureus Strains Occur Frequently Enough To Represent a Risk of False-Positive Methicillin-Resistant S. aureus Determinations by Molecular Methods?
Becker et al.
J. Clin. Microbiol. 2006;44:229-231.
ABSTRACT | FULL TEXT  

Nosocomial MRSA Infection in Vascular Surgery Patients: Impact on Patient Outcome
Cowie et al.
VASC ENDOVASCULAR SURG 2005;39:327-334.
ABSTRACT  

Detection of Methicillin-Resistant Staphylococcus aureus Directly from Nasal Swab Specimens by a Real-Time PCR Assay
Warren et al.
J. Clin. Microbiol. 2004;42:5578-5581.
ABSTRACT | FULL TEXT  

Impact of Methicillin Resistance on Outcome of Staphylococcus aureus Ventilator-associated Pneumonia
Combes et al.
Am. J. Respir. Crit. Care Med. 2004;170:786-792.
ABSTRACT | FULL TEXT  

Clinical and Economic Analysis of Methicillin-Susceptible and -Resistant Staphylococcus aureus Infections
Kopp et al.
The Annals of Pharmacotherapy 2004;38:1377-1382.
ABSTRACT | FULL TEXT  

Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia
Kim et al.
J Antimicrob Chemother 2004;54:489-497.
ABSTRACT | FULL TEXT  

Clinical Identifiers of Complicated Staphylococcus aureus Bacteremia
Fowler et al.
Arch Intern Med 2003;163:2066-2072.
ABSTRACT | FULL TEXT  

Is MRSA More Pathogenic in Critically Ill Patients?
Kaw
Arch Intern Med 2003;163:739-740.
FULL TEXT  

Epidemiology and Prognostic Determinants of Bloodstream Infections in Surgical Intensive Care
Harbarth et al.
Arch Surg 2002;137:1353-1359.
ABSTRACT | FULL TEXT  

Outcome and Attributable Mortality in Critically Ill Patients With Bacteremia Involving Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus
Blot et al.
Arch Intern Med 2002;162:2229-2235.
ABSTRACT | FULL TEXT  

Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in HIV-infected patients
Tumbarello et al.
J Antimicrob Chemother 2002;50:375-382.
ABSTRACT | FULL TEXT  

Health and Economic Outcomes of the Emergence of Third-Generation Cephalosporin Resistance in Enterobacter Species
Cosgrove et al.
Arch Intern Med 2002;162:185-190.
ABSTRACT | FULL TEXT  

Treatment and Outcome of Staphylococcus aureus Bacteremia: A Prospective Study of 278 Cases
Jensen et al.
Arch Intern Med 2002;162:25-32.
ABSTRACT | FULL TEXT  

Infection Control in the ICU
Eggimann and Pittet
Chest 2001;120:2059-2093.
ABSTRACT | FULL TEXT  

Relationships between Enterococcal Virulence and Antimicrobial Resistance
Mundy et al.
Clin. Microbiol. Rev. 2000;13:513-522.
ABSTRACT | FULL TEXT  

Prospective Analysis of Staphylococcus aureus Bacteremia in Nonneutropenic Adults With Malignancy
Gopal et al.
JCO 2000;18:1110-1110.
ABSTRACT | FULL TEXT  

Control of Endemic Methicillin-Resistant Staphylococcus aureus: A Cost-Benefit Analysis in an Intensive Care Unit
Chaix et al.
JAMA 1999;282:1745-1751.
ABSTRACT | FULL TEXT  

Prediction of Poorer Prognosis by Infection With Antibiotic-Resistant Gram-positive Cocci Than by Infection With Antibiotic-Sensitive Strains
Gleason et al.
Arch Surg 1999;134:1033-1040.
ABSTRACT | FULL TEXT  

Enterococcal Infection in the ICU: At the Precipice of a Postantibiotic Era: Linden PK Enterococcal Infection in the ICU At the Precipice of a Postantibiotic Era J Intensive Care Med 1999,14 59-61
Linden
J Intensive Care Med 1999;14:59-61.
 

Staphylococcus aureus Infections
Blot et al.
NEJM 1998;339:2025-2027.
FULL TEXT